This study will evaluate the safety and performance of VYC-25L hyaluronic acid injectable gel for the restoration and creation of facial volume in participants seeking to increase projection of the chin and/or jaw.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
120
Hyaluronic Acid Injectable Gel (VYC-25L) injection into the chin and/or jaw areas (up to 4.0 mLs).
Cabinet medical Solferino
Paris, France
Centre de Chirurgie Esthetique
Toulouse, France
Hautzentrum Altenbochum - RuhrDERM Gemeinschaftspraxis Dr. med. Ardabili - Dr. med. Niesmann
Bochum, Germany
Change from Baseline in the Glabella-Subnasale-Pogonion (G-Sn-Pog) Angle
Time frame: Baseline, Month 3
Percentage of Responders based on the Investigator's Assessment of Improvement in the Chin and Jaw Area using the 5-point Global Aesthetic Improvement Scale (GAIS)
Time frame: Month 3
Percentage of Responders based on the Participant's Assessment of Improvement in the Chin and Jaw Area using the 5-point GAIS
Time frame: Month 3
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
Dermatolgie Köln am Rhein
Cologne, Germany
Rosenpark Research Geschäftsbereich der Rosenparkklinik GmbH
Darmstadt, Germany
Rotes Kreuz Krankenhaus Kassel Gemeinnützige GmbH Klinik für Plastische, Rekonstruktive und Ästhetische Chirurgie
Kassel, Germany
Praxisgemeinschaft Theatiner46 Dres. Ogilvie und Dr. Bernd Schuster
Munich, Germany
Dermatogische Privatpraxis CentroDerm GmbH
Wuppertal, Germany
Kliniek Dokter Frodo Gaymans
Amsterdam, Netherlands
Joost Kroon Cosmetische Kliniek
Amsterdam, Netherlands